299 related articles for article (PubMed ID: 1519526)
21. Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
Niebauer M; Daoud E; Goyal R; Chan KK; Harvey M; Bogun F; Castellani M; Man KC; Strickberger SA; Morady F
Am Heart J; 1996 Mar; 131(3):516-8. PubMed ID: 8604631
[TBL] [Abstract][Full Text] [Related]
22. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
[TBL] [Abstract][Full Text] [Related]
23. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269
[TBL] [Abstract][Full Text] [Related]
24. Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: a new highly sensitive and specific protocol.
Belhassen B; Shapira I; Sheps D; Laniado S
Am J Cardiol; 1990 Mar; 65(9):615-22. PubMed ID: 2309631
[TBL] [Abstract][Full Text] [Related]
25. Effect of high-current stimulation in patients with sustained ventricular tachycardia rendered noninducible by antiarrhythmic drugs.
Hook BG; Marchlinski FE; Josephson ME; Buxton AE
Am J Cardiol; 1992 Sep; 70(7):752-7. PubMed ID: 1519525
[TBL] [Abstract][Full Text] [Related]
26. Long-term reproducibility of responses to programmed cardiac stimulation in spontaneous ventricular tachyarrhythmias.
Schoenfeld MH; McGovern B; Garan H; Ruskin JN
Am J Cardiol; 1984 Sep; 54(6):564-8. PubMed ID: 6475774
[TBL] [Abstract][Full Text] [Related]
27. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the characteristics of nonsustained ventricular tachycardia on Holter monitoring and sustained ventricular tachycardia observed spontaneously or induced by programmed stimulation.
Kim SG; Mercando AD; Fisher JD
Am J Cardiol; 1987 Aug; 60(4):288-92. PubMed ID: 3618487
[TBL] [Abstract][Full Text] [Related]
29. Induction of clinical ventricular tachycardia using programmed stimulation: value of third and fourth extrastimuli.
Mann DE; Luck JC; Griffin JC; Herre JM; Limacher MC; Magro SA; Robertson NW; Wyndham CR
Am J Cardiol; 1983 Sep; 52(5):501-6. PubMed ID: 6613871
[TBL] [Abstract][Full Text] [Related]
30. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current.
Cua M; Veltri EP
Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):382-6. PubMed ID: 7681187
[TBL] [Abstract][Full Text] [Related]
31. Predictors of ventricular tachycardia inducibility in programmed electrical stimulation and the effectiveness of serial drug testing: Polish multicenter study.
Wnuk-Wojnar AM; Giec L; Drzewiecki J; Trusz-Gluza M; Dabrowski A; Pasyk S
Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2127-32. PubMed ID: 1704606
[TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
33. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
34. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.
Manolis AS; Estes NA
Am J Cardiol; 1990 Jan; 65(3):201-5. PubMed ID: 2296889
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
[TBL] [Abstract][Full Text] [Related]
37. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.
Lemery R; Brugada P; Bella PD; Dugernier T; van den Dool A; Wellens HJ
Circulation; 1989 May; 79(5):990-9. PubMed ID: 2713978
[TBL] [Abstract][Full Text] [Related]
38. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.
Brugada P; Green M; Abdollah H; Wellens HJ
Circulation; 1984 Jan; 69(1):87-92. PubMed ID: 6689650
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the need to modify antiarrhythmic therapy because of drug intolerance or inefficacy in patients evaluated by electrophysiology study.
Ujhelyi MR; Fisher JR; Chow MS; Kluger J
Am Heart J; 1993 Aug; 126(2):352-9. PubMed ID: 8338006
[TBL] [Abstract][Full Text] [Related]
40. Role of extrastimulus prematurity and intraventricular conduction time in inducing ventricular tachycardia or ventricular fibrillation secondary to coronary artery disease.
Gillis AM; Winkle RA; Echt DS
Am J Cardiol; 1987 Sep; 60(7):590-5. PubMed ID: 3630942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
